Loading...
XJPX
3902
Market cap115mUSD
Dec 05, Last price  
474.00JPY
1D
0.00%
1Q
-20.60%
Jan 2017
-22.93%
IPO
30.76%
Name

Medical Data Vision Co Ltd

Chart & Performance

D1W1MN
XJPX:3902 chart
P/E
P/S
3.04
EPS
Div Yield, %
1.37%
Shrs. gr., 5y
-0.95%
Rev. gr., 5y
7.97%
Revenues
5.91b
-7.98%
1,530,432,0001,950,737,0002,413,786,0002,632,390,0003,225,842,0003,577,612,0004,026,576,0004,579,731,0005,672,300,0006,104,599,0006,419,026,0005,906,958,000
Net income
-791m
L
204,925,000135,461,000164,010,000178,209,000354,599,00069,470,000554,315,000700,220,0001,087,267,000870,509,000979,125,000-791,170,000
CFO
-878m
L
285,591,000206,150,000118,336,000196,378,000486,214,000120,200,0001,202,240,000964,366,0001,082,616,000910,795,0001,616,314,000-877,849,000
Dividend
Dec 29, 20259 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Medical Data Vision Co., Ltd. develops, produces, maintains, and sells medical information integration systems in Japan. The company also offers medical data analysis, survey, and consulting services; management consulting services for medical institutions; and medical data services, as well as plans, designs, develops, and operates portal sites. It provides its services to pharmaceutical companies, medical device manufacturer, academia, research institution, and health insurance providers. The company was founded in 2003 and is headquartered in Tokyo, Japan.
IPO date
Dec 16, 2014
Employees
257
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT